Indication

Staphylococcal prosthetic heart valve endocarditis

Staphylococcal prosthetic heart valve endocarditis is a severe, life-threatening infection of mechanical or bioprosthetic cardiac valves caused by staphylococcal species, predominantly *Staphylococcus aureus* or coagulase-negative staphylococci such as *Staphylococcus epidermidis*. Read more about Staphylococcal prosthetic heart valve endocarditis

76 drugs 46 manufacturers

Advertisement

Drugs that treat it

Common Staphylococcal prosthetic heart valve endocarditis therapies.

Showing 46–54 of 76 drugs

NAFCILLIN SODIUM

BETA-LACTAMS·STAPHYLOCOCCUS AUREUS SEPTICEMIA·+10
NORTHSTAR RX LL

VANCOMYCIN HCL

VANCOMYCIN INTRAVENOUS·CLOSTRIDIOIDES DIFFICILE INFECTION·+18
NORTHSTAR RX LL

VANCOMYCIN HCL

VANCOMYCIN INTRAVENOUS·CLOSTRIDIOIDES DIFFICILE INFECTION·+18
SAGENT PHARMACE

VANCOMYCIN HCL

VANCOMYCIN INTRAVENOUS·CLOSTRIDIOIDES DIFFICILE INFECTION·+18
CAMBER PHARMACE

NAFCILLIN SODIUM

BETA-LACTAMS·STAPHYLOCOCCUS AUREUS SEPTICEMIA·+10
METHAPHARM INC

VANCOMYCIN HCL

VANCOMYCIN INTRAVENOUS·CLOSTRIDIOIDES DIFFICILE INFECTION·+18
SLATE RUN PHARM
Filter & compare in the drug finder →Opens the drug finder with Staphylococcal prosthetic heart valve endocarditis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Staphylococcal prosthetic heart valve endocarditis.

Staphylococcal prosthetic heart valve endocarditis is a severe, life-threatening infection of mechanical or bioprosthetic cardiac valves caused by staphylococcal species, predominantly *Staphylococcus aureus* or coagulase-negative staphylococci such as *Staphylococcus epidermidis*.

The disease affects the cardiovascular system of individuals who have undergone surgical or transcatheter valve replacement.

Pathophysiologically, the bacteria adhere to the prosthetic material or damaged peri-annular tissue, forming adherent biofilms and destructive vegetations that frequently lead to invasive intracardiac complications, including perivalvular abscesses, valve dehiscence, and severe regurgitation.

Clinically, it typically presents with persistent bacteremia, fever, new or changing murmurs, and acute heart failure, accompanied by a high propensity for systemic septic embolization.

Personalize your experience

Follow Staphylococcal prosthetic heart valve endocarditis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it